Related Experiment Video
Updated: Jul 27, 2026
12:24
Noninvasive Assessment of Cardiac Abnormalities in Experimental Autoimmune Myocarditis by Magnetic Resonance Microscopy Imaging in the Mouse
Published on: June 20, 2014
[The heart in dermatomyositis and polymyositis ]
Archivos Del Instituto De Cardiologia De Mexico
|January 1, 1986
Summary
A study of patients with Dermatomyositis (DM) and Polymyositis (PM) found that 82% experienced cardiopulmonary complications. Non-invasive cardiac assessments revealed frequent abnormalities, highlighting the significant cardiac impact of these inflammatory myopathies.
Area of Science:
- Cardiology
- Rheumatology
- Internal Medicine
Context:
- Inflammatory myopathies, including Dermatomyositis (DM) and Polymyositis (PM), can affect multiple organ systems.
- Cardiac involvement is a recognized but often underdiagnosed complication in these conditions.
Purpose:
- To investigate the cardiological status of patients with DM and PM using non-invasive methods.
- To identify the prevalence and types of cardiopulmonary complications in this patient cohort.
Summary:
- Eleven consecutive patients (8 DM, 3 PM) underwent non-invasive cardiological evaluation.
- Eighty-two percent (9/11) exhibited cardiopulmonary complications.
- Common findings included abnormal electrocardiograms (ECG), cardiac enlargement (right atrial/ventricular hypertrophy, left ventricular hypertrophy), bundle branch blocks, and echocardiographic abnormalities such as right ventricular hypertrophy, mitral valve prolapse (MVP), and congestive cardiomyopathy.
Impact:
- This study underscores the high incidence of cardiopulmonary involvement in DM and PM patients.
- Findings emphasize the need for routine non-invasive cardiac screening in these individuals.
- Early detection and management of cardiac complications can potentially improve patient outcomes.
Related Concept Videos
01:15Layers of the Heart Wall
The heart wall comprises three distinct layers: the epicardium, myocardium, and endocardium. The outermost layer, the epicardium, is the visceral layer of the serous pericardium, featuring a thin, transparent mesothelial surface and an inner layer of areolar connective tissue with fat deposits that increase with age.
The myocardium, the thickest layer, consists of cardiac muscle cells interconnected by intercalated discs and crisscrossing connective tissue fibers. These muscle fibers contract...
The myocardium, the thickest layer, consists of cardiac muscle cells interconnected by intercalated discs and crisscrossing connective tissue fibers. These muscle fibers contract...
01:21Myocarditis I: Introduction
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
01:27Myocarditis II: Clinical Features and Diagnostic Tests
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
01:14Myocarditis III: Medical Management
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
01:23Rheumatic Heart Disease I: Introduction
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
01:22Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...